Scanning NSE · BSE · NYSE · NASDAQ

Halozyme Therapeutics, Inc. - (HALO) share price

Halozyme Therapeutics, Inc. - (NASDAQ:HALO) last traded at $103.63, down 15.72% on the day (quote 2026-11-06 21:00 UTC), with a market cap of $11.81B and a 52-week range of $61.23 to $134.

Key facts for Halozyme Therapeutics, Inc. -
ExchangeNASDAQ
CurrencyUSD
Last price$103.63
1-day move-15.72%
52-week range$61.23 - $134
Market cap$11.81B
From 52-week high-22.70%
Volume vs average2.7x
Falling Shares risk score59/100 (HIGH)
CountryUnited States

Frequently asked questions

Why is Halozyme Therapeutics, Inc. - falling today?

Halozyme Therapeutics, Inc. - (NASDAQ:HALO) is down 15.72% at its latest quote and trades 22.7% below its 52-week high, on volume 2.7x its average. A price fall alone does not identify a cause: Falling Shares Intelligence links a move to a filing, order or news item only when a source supports it.

What is the Halozyme Therapeutics, Inc. - share price today?

Halozyme Therapeutics, Inc. - (NASDAQ:HALO) last traded at $103.63, a -15.72% move on the day as of 2026-11-06 21:00 UTC. Market data comes from public feeds and may be delayed; it is not investment advice.

What is the 52-week range of Halozyme Therapeutics, Inc. -?

Halozyme Therapeutics, Inc. -'s 52-week low is $61.23 and its 52-week high is $134; the shares trade 22.7% below the high.

What is the market cap of Halozyme Therapeutics, Inc. -?

Halozyme Therapeutics, Inc. - has a market capitalisation of about $11.81B at the latest price.

What are the risks of investing in Halozyme Therapeutics, Inc. -?

Falling Shares Intelligence rates Halozyme Therapeutics, Inc. - 59/100 (HIGH) on price stress, volume and disclosure signals. Risk scores are analytical indicators, not allegations or investment advice. Review exchange filings and the company's own disclosures before any decision.

Data is compiled from public exchange feeds and may be delayed. Not investment advice.

Wung Thomas, Editor-in-Chief: wungthomas@fallingshares.com. General enquiries and corrections: info@fallingshares.com